Bavarian Nordic Is A Biotechnology Company That Focuses On Vaccine Developmentmanufacturingand Commercializationfounded In 1994It Is Headquartered In Hellerupdenmarkand Operates Globally In Europe And North Americathe Company Employs Around 1 379 People And Reported A Revenue Of 7 062 Billion Dkk In 2023 Bavarian Nordic Specializes In Vaccines For Infectious Disease Preventionits Product Portfolio Includes Fda Approved Vaccines For Smallpox And Mpoxas Well As Vaccines For Rabiestick Borne Encephalitistyphoidand Cholerathe Company Utilizes Advanced Technologies For Developing Novel Vaccines And Has Manufacturing Facilities In Denmark And Switzerlandit Also Engages In Research And Development To Enhance Vaccine Platforms For Emerging Infectious Diseases And Biodefensebavarian Nordic Collaborates With Government Entitieshealthcare Systemsand Global Organizations To Support Public Health Initiatives And Outbreak Responses
